[1]万 涛,倪 彬,刘建伟,等.人胆管癌相关基因CCR-L2/FXYD6大片段克隆与鉴定[J].中华实验外科杂志,2003,20(5): 393-395.
[2]肖 梅,周宁新,高丽杰,等.半定量检测胆管癌组织中人FXYD6基因的表达[J].中国普外基础与临床杂志,2008,15(2):83-87.
[3]Sweadner KJ, Rael E. The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression[J]. Genomics, 2000,68(1):41-56.
[4]Strazzabosco M. New insights into cholangiocyte physiology [J]. J Hepatology, 1997,27(5):945-952.
[5]肖 梅,周宁新,万 涛,等.RT-PCR法检测人FXYD6基因在胆道良恶性肿瘤中的表达[J].肝胆外科杂志,2007,15(3):223-225.
[6]窦春青,岳 鑫,周宁新. hFXYD6反义核酸对胆管癌细胞体外增殖和侵袭能力的影响[J]. 世界华人消化杂志,2007,15(9):929-935.
[7]刘军桂,周宁新,张效东. FXYD6 shRNA表达载体的构建及其在体外对胰腺癌细胞增殖的影响[J]. 生物技术通讯,2009,20(4):458-461.
[8]Kayed H, Kleeff J, Kolb A, et al. FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth [J]. In J Cancer, 2006,118(1):43-54.
[9]张志清,姚立红,侯云德,等.含PLPR启动子的原核高效表达载体的组建及其应用[J].病毒学报,1990,6(2):111.